Love this partnership with AZN. Coverage initiated today with a $30 target and the stock is at $18. Looking for a nice run in the next month or two.
Sentiment: Strong Buy
ABSOLUTELY NO TRIAL DATA FOR DIABETES!!!!!!!!!!!!!!!
HEE HEE HEE HEE HEE
Sentiment: Strong Sell
I could easily see Mylan swooping in and buying MNTA for $30-35/share and consolidate the Copaxone drug launch for September. And the real kicker is to get the Pancreactic Cancer Drug under development that is gaining fast track status because of their success with it thus far. This drug alone has multi billion market potenital and it is proprietary, 80% margins!! Hugely profitable and a major win on two fronts. A company that is turning profitable with $190 mil cash/ No debt and a huge cancer drug in pipeline along with several strong Biosims coming down the pike of development, including the Copaxone launch!
I see it happening with MYL or TEVA who may want to protect their Copaxone interest and gain the Pancreatic Cancer drug in development
Research the Pancreatic Cancer drug under development. It is about to get fast tracked because the results have been promising. Could lead to multiple applications and be a multiple Billion dollar home run drug!!
A big pharma may want entry into the BIOSIM space and the Pancreatic Cancer drug has multi billion potential!!
Thanks for the Friday chuckle! Two pharma companies in desperate need to fill their product pipelines so you are saying 2+2=3, did you go to an SEC conference MBA program?
May be AZN buying somebody. I saw something on message board but did not pat attention. If I remember, it might have been BMRN board today.
Sentiment: Strong Buy
Merck.....buyout of AZN?
Dream on dude.
Nobody wants to go near AZN as long as your boy Soriat is on the premises.
Still has room to drop to get in line with the rest of the industry. This will happen one of two ways...either the share price will drop or the earnings will rise. Since they are predicting continued decline in revenue for two more years, then it will be due to a lower share price.
What is your basis for saying this? Do you really think they would offer 100 a share or higher? More than Pfizer? Could be, but if there were any talks going on, I would have expected to see AZN start ramping up again as it did when the PFE rumors started and then proven true. Nice try though...oh, and if it does prove to be true, I have no problems acknowledging your post as stating such.